BioPharmX to Present at Oppenheimer's 28th Annual Healthcare Conference
Mar 14, 2018
MENLO PARK, Calif., March 14, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing dermatology products, today announces that it will present its updated corporate presentation at Oppenheimer's 28th Annual Healthcare Conference in New York, where it will also be webcast live.
BioPharmX President and Co-founder Anja Krammer, will present the company's updated overview at the conference on Wednesday, March 21, at 10:55 a.m. EDT at The Westin New York Grand Central.
The live webcast will be available at https://www.veracast.com/webcasts/opco/healthcare2018/47207475132.cfm and a replay will be accessible for 90 days following the presentation.
Oppenheimer's Annual Healthcare Conference hosts a broad spectrum of public and private companies who are leaders and pioneers in the biopharmaceutical, biotechnology, medical device, life science tools & diagnostics, health technology & distribution, and healthcare facility, provider and service industries. It is anticipated, once again, to be one of the most important investor conferences in this sector.
About BioPharmX® Corporation
BioPharmX Corporation (NYSE American: BPMX) is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through proprietary platform technologies for prescription, over-the-counter (OTC), and supplement applications in the health and wellness markets, including dermatology and women's health. To learn more about BioPharmX, visit www.BioPharmX.com.
BioPharmX is a registered trademark of BioPharmX, Inc.
SOURCE BioPharmX Corporation
For further information: Nina Brauer, Senior Manager, Marketing & Communications, email@example.com, (650) 889-5030 or Investors, firstname.lastname@example.org